$1.54 Billion is the total value of Nantahala Capital Management's 118 reported holdings in Q4 2022. The portfolio turnover from Q3 2022 to Q4 2022 was 43.3% .
| Value | Shares | ↓ Weighting | ||||||
|---|---|---|---|---|---|---|---|---|
| IWM | Buy | ISHARES TRput | $296,412,000 | +58.4% | 1,700,000 | +49.8% | 19.21% | +58.6% |
| IWM | Buy | ISHARES TRrussell 2000 etf | $120,496,011 | +869.4% | 691,076 | +816.9% | 7.81% | +871.4% |
| ESTA | Sell | ESTABLISHMENT LABS HLDGS INC | $119,156,260 | +15.8% | 1,815,023 | -3.7% | 7.72% | +16.0% |
| QURE | Sell | UNIQURE NV | $61,214,418 | +12.4% | 2,700,239 | -7.0% | 3.97% | +12.6% |
| CASH | Sell | PATHWARD FINANCIAL INC | $56,016,574 | +28.0% | 1,301,198 | -2.0% | 3.63% | +28.2% |
| TA | Sell | TRAVELCENTERS OF AMERICA INC | $46,185,823 | -21.9% | 1,031,394 | -6.0% | 2.99% | -21.8% |
| IMAX | Buy | IMAX CORP | $41,002,393 | +7.4% | 2,796,889 | +3.5% | 2.66% | +7.6% |
| APEN | Buy | APOLLO ENDOSURGERY INC | $40,444,571 | +84.7% | 4,056,627 | +2.1% | 2.62% | +85.0% |
| KROS | Sell | KEROS THERAPEUTICS INC | $38,036,306 | +19.6% | 792,093 | -6.3% | 2.46% | +19.7% |
| LXFR | Buy | LUXFER HLDGS PLC | $33,645,817 | -0.7% | 2,452,319 | +4.9% | 2.18% | -0.5% |
| IMAX | IMAX CORPcall | $32,124,458 | +3.8% | 2,191,300 | 0.0% | 2.08% | +4.0% | |
| RDVT | Sell | RED VIOLET INC | $29,352,526 | +32.5% | 1,275,088 | -0.3% | 1.90% | +32.6% |
| QURE | Buy | UNIQURE NVcall | $26,925,159 | +43.5% | 1,187,700 | +18.8% | 1.74% | +43.7% |
| SNDX | Sell | SYNDAX PHARMACEUTICALS INC | $24,831,692 | -24.9% | 975,705 | -29.1% | 1.61% | -24.8% |
| IMTX | Buy | IMMATICS N.V | $23,939,670 | -11.8% | 2,748,527 | +1.3% | 1.55% | -11.6% |
| RMR | Sell | RMR GROUP INCcl a | $23,904,218 | +10.7% | 846,167 | -7.1% | 1.55% | +10.9% |
| TNL | Sell | TRAVEL PLUS LEISURE CO | $22,876,636 | -27.6% | 628,479 | -32.2% | 1.48% | -27.5% |
| MLHR | Sell | MILLERKNOLL INC | $21,039,939 | -13.7% | 1,001,425 | -35.9% | 1.36% | -13.5% |
| CDXS | Sell | CODEXIS INC | $20,913,064 | -23.4% | 4,487,782 | -0.4% | 1.36% | -23.3% |
| APEN | APOLLO ENDOSURGERY INCcall | $19,940,000 | +80.9% | 2,000,000 | 0.0% | 1.29% | +81.2% | |
| PAYA | Sell | PAYA HOLDINGS INC | $19,432,939 | +8.3% | 2,472,352 | -15.8% | 1.26% | +8.5% |
| DHX | Sell | DHI GROUP INC | $19,371,853 | -12.0% | 3,661,976 | -10.5% | 1.26% | -11.9% |
| PTON | Buy | PELOTON INTERACTIVE INC | $19,017,761 | +18.5% | 2,395,184 | +3.4% | 1.23% | +18.7% |
| GDEN | Sell | GOLDEN ENTMT INC | $17,058,477 | +1.4% | 456,109 | -5.4% | 1.11% | +1.7% |
| HGV | New | HILTON GRAND VACATIONS INC | $15,924,728 | – | 413,200 | +100.0% | 1.03% | – |
| ALTG | Sell | ALTA EQUIPMENT GROUP INC | $15,682,712 | +8.4% | 1,188,985 | -9.5% | 1.02% | +8.4% |
| AUTL | Buy | AUTOLUS THERAPEUTICS PLCspon ads | $14,785,834 | +32.5% | 7,782,018 | +49.2% | 0.96% | +32.7% |
| CBAY | Sell | CYMABAY THERAPEUTICS INC | $14,111,005 | +62.9% | 2,250,559 | -9.1% | 0.92% | +63.4% |
| VMD | Sell | VIEMED HEALTHCARE INC | $13,381,200 | +24.6% | 1,770,000 | -1.1% | 0.87% | +24.7% |
| HLF | HERBALIFE NUTRITION LTDcall | $12,911,376 | -25.2% | 867,700 | 0.0% | 0.84% | -25.1% | |
| MAX | Sell | MEDIAALPHA INCcl a | $12,768,238 | -6.4% | 1,283,240 | -17.7% | 0.83% | -6.2% |
| PTON | PELOTON INTERACTIVE INCcall | $10,866,684 | +14.6% | 1,368,600 | 0.0% | 0.70% | +14.7% | |
| RH | RHcall | $10,687,600 | +8.6% | 40,000 | 0.0% | 0.69% | +8.8% | |
| Buy | DARIOHEALTH CORP | $10,557,720 | +3.9% | 2,466,757 | +12.4% | 0.68% | +4.0% | |
| AMYT | AMRYT PHARMA PLCsponsored ads | $10,493,443 | +5.5% | 1,437,458 | 0.0% | 0.68% | +5.6% | |
| CNCE | Sell | CONCERT PHARMACEUTICALS INC | $10,117,146 | -15.5% | 1,732,388 | -3.1% | 0.66% | -15.4% |
| RMBL | Buy | RUMBLEON INC | $9,636,360 | +140.3% | 1,489,391 | +528.5% | 0.62% | +140.4% |
| DXPE | Sell | DXP ENTERPRISES INC | $9,314,380 | -66.1% | 338,090 | -70.9% | 0.60% | -66.1% |
| Buy | AURA BIOSCIENCES INC | $8,386,886 | +20.6% | 798,751 | +108.1% | 0.54% | +20.9% | |
| BVS | Buy | BIOVENTUS INC | $8,269,978 | +211.8% | 3,168,574 | +736.4% | 0.54% | +211.6% |
| RDI | Sell | READING INTL INCcl a | $8,054,534 | -16.1% | 2,907,774 | -0.3% | 0.52% | -15.9% |
| RH | Sell | RH | $7,694,270 | -43.8% | 28,797 | -48.3% | 0.50% | -43.7% |
| PAYO | Buy | PAYONEER GLOBAL INC | $7,663,314 | +228.8% | 1,084,831 | +181.5% | 0.50% | +229.1% |
| LYRA | Sell | LYRA THERAPEUTICS INC | $6,973,406 | -38.0% | 2,220,830 | -1.1% | 0.45% | -37.9% |
| PRDO | PERDOCEO ED CORPput | $6,950,000 | +35.0% | 500,000 | 0.0% | 0.45% | +35.1% | |
| TSHA | Buy | TAYSHA GENE THERAPIES INC | $6,779,469 | +108.9% | 2,999,765 | +86.2% | 0.44% | +109.0% |
| ZM | New | ZOOM VIDEO COMMUNICATIONS INcall | $6,774,000 | – | 100,000 | +100.0% | 0.44% | – |
| ESTA | New | ESTABLISHMENT LABS HLDGS INCcall | $6,565,000 | – | 100,000 | +100.0% | 0.42% | – |
| FBIO | Sell | FORTRESS BIOTECH INC | $5,219,077 | -26.6% | 7,968,056 | -3.6% | 0.34% | -26.5% |
| Buy | VENTYX BIOSCIENCES INC | $5,181,902 | +27.3% | 158,033 | +35.5% | 0.34% | +27.3% | |
| PWP | Sell | PERELLA WEINBERG PARTNERS | $4,941,929 | +54.5% | 239,819 | -52.5% | 0.32% | +54.6% |
| RNG | Sell | RINGCENTRAL INCcl a | $4,871,819 | -27.3% | 137,622 | -17.9% | 0.32% | -27.0% |
| IDYA | IDEAYA BIOSCIENCES INC | $4,605,732 | +21.8% | 253,480 | 0.0% | 0.30% | +22.0% | |
| New | ABEONA THERAPEUTICS INC | $4,187,835 | – | 272,731 | +100.0% | 0.27% | – | |
| PNT | Buy | POINT BIOPHARMA GLOBAL INC | $4,171,272 | +172.8% | 572,191 | +189.3% | 0.27% | +172.7% |
| New | WEBER INCcl a | $4,025,000 | – | 500,000 | +100.0% | 0.26% | – | |
| TELA | TELA BIO INC | $4,013,523 | +35.0% | 349,002 | 0.0% | 0.26% | +35.4% | |
| FULC | New | FULCRUM THERAPEUTICS INC | $3,640,000 | – | 500,000 | +100.0% | 0.24% | – |
| PAR TECHNOLOGY CORPnote 2.875% 4/1 | $3,567,362 | -5.1% | 3,785,000 | 0.0% | 0.23% | -4.9% | ||
| Sell | APTOSE BIOSCIENCES INC | $3,510,663 | -14.4% | 6,052,867 | -12.1% | 0.23% | -14.0% | |
| SSKN | STRATA SKIN SCIENCES INC | $3,471,451 | -9.3% | 4,393,685 | 0.0% | 0.22% | -9.3% | |
| AAN | Buy | THE AARONS COMPANY INC | $3,448,435 | +76.1% | 288,572 | +43.2% | 0.22% | +76.4% |
| MED | New | MEDIFAST INC | $3,460,500 | – | 30,000 | +100.0% | 0.22% | – |
| CDTX | Sell | CIDARA THERAPEUTICS INC | $3,303,113 | +13.0% | 4,367,464 | -4.2% | 0.21% | +13.2% |
| MDXG | New | MIMEDX GROUP INC | $3,190,117 | – | 1,147,524 | +100.0% | 0.21% | – |
| ACER | Buy | ACER THERAPEUTICS INC | $3,077,739 | +217.9% | 1,226,191 | +76.0% | 0.20% | +215.9% |
| New | DISC MEDICINE INC | $3,063,181 | – | 162,762 | +100.0% | 0.20% | – | |
| Sell | AVALO THERAPEUTICS INC | $2,725,016 | +49.8% | 540,667 | -1.3% | 0.18% | +50.0% | |
| DHC | New | DIVERSIFIED HEALTHCARE TR | $2,726,262 | – | 4,215,000 | +100.0% | 0.18% | – |
| OPTN | New | OPTINOSE INC | $2,682,500 | – | 1,450,000 | +100.0% | 0.17% | – |
| IMTXW | Sell | IMMATICS N.V*w exp 07/01/202 | $2,475,114 | -7.5% | 986,101 | -0.1% | 0.16% | -7.5% |
| SRL | Sell | SCULLY ROYALTY LTD | $2,436,437 | +3.4% | 316,010 | -0.8% | 0.16% | +3.3% |
| MACK | Sell | MERRIMACK PHARMACEUTICALS IN | $2,406,600 | +49.4% | 210,000 | -51.1% | 0.16% | +50.0% |
| RILY | B. RILEY FINANCIAL INC | $2,335,723 | -23.2% | 68,296 | 0.0% | 0.15% | -23.4% | |
| AGLE | Buy | AEGLEA BIOTHERAPEUTICS INC | $2,074,625 | +6.3% | 4,611,302 | +24.3% | 0.13% | +6.3% |
| ENVA | New | ENOVA INTL INC | $2,043,202 | – | 53,250 | +100.0% | 0.13% | – |
| KROS | KEROS THERAPEUTICS INCcall | $2,012,038 | +27.7% | 41,900 | 0.0% | 0.13% | +27.5% | |
| BMTX | New | BM TECHNOLOGIES INC | $1,603,513 | – | 307,776 | +100.0% | 0.10% | – |
| New | AKUMIN INC | $1,586,363 | – | 2,206,960 | +100.0% | 0.10% | – | |
| VRM | VROOM INCcall | $1,530,000 | -12.1% | 1,500,000 | 0.0% | 0.10% | -12.4% | |
| WNC | New | WABASH NATL CORPput | $1,507,420 | – | 66,700 | +100.0% | 0.10% | – |
| RZLT | REZOLUTE INC | $1,487,784 | -24.4% | 718,736 | 0.0% | 0.10% | -24.4% | |
| ANEB | ANEBULO PHARMACEUTICALS INC | $1,238,688 | -13.4% | 511,073 | 0.0% | 0.08% | -14.0% | |
| SOLENO THERAPEUTICS INC | $1,196,274 | +18.6% | 604,179 | 0.0% | 0.08% | +20.0% | ||
| AGS | PLAYAGS INC | $1,134,842 | -3.7% | 222,518 | 0.0% | 0.07% | -2.6% | |
| CRMT | New | AMERICAS CAR-MART INC | $1,083,900 | – | 15,000 | +100.0% | 0.07% | – |
| DS | New | DRIVE SHACK INC | $1,072,825 | – | 6,500,000 | +100.0% | 0.07% | – |
| LQDA | LIQUIDIA CORPORATION | $935,065 | +17.0% | 146,792 | 0.0% | 0.06% | +17.3% | |
| ADCT | New | ADC THERAPEUTICS SA | $934,234 | – | 243,290 | +100.0% | 0.06% | – |
| ANGN | Sell | ANGION BIOMEDICA CORP | $838,500 | -14.5% | 1,033,145 | -3.1% | 0.05% | -14.3% |
| DAKT | New | DAKTRONICS INC | $823,967 | – | 292,187 | +100.0% | 0.05% | – |
| IDWM | Sell | IDW MEDIA HLDGS INCcl b | $785,857 | -50.9% | 836,019 | -19.6% | 0.05% | -51.0% |
| CVNA | New | CARVANA COcall | $711,000 | – | 150,000 | +100.0% | 0.05% | – |
| SGRP | SPAR GROUP INC | $699,955 | -10.4% | 538,427 | 0.0% | 0.04% | -11.8% | |
| NPCE | Sell | NEUROPACE INC | $646,037 | -61.2% | 433,582 | -2.2% | 0.04% | -61.1% |
| NAUT | Sell | NAUTILUS BIOTECHNOLOGY INC | $521,721 | -62.4% | 289,845 | -55.8% | 0.03% | -62.2% |
| AVTE | New | AEROVATE THERAPEUTICS INC | $460,010 | – | 15,700 | +100.0% | 0.03% | – |
| HYPERFINE INC | $457,741 | +2.2% | 544,930 | 0.0% | 0.03% | +3.4% | ||
| New | JOURNEY MED CORP | $433,912 | – | 225,996 | +100.0% | 0.03% | – | |
| CRIS | Sell | CURIS INC | $437,933 | -82.0% | 796,241 | -76.7% | 0.03% | -82.3% |
| TACT | TRANSACT TECHNOLOGIES INC | $415,464 | +73.1% | 65,738 | 0.0% | 0.03% | +68.8% | |
| Sell | LUCID DIAGNOSTICS INC | $380,170 | -13.2% | 279,537 | -2.4% | 0.02% | -10.7% | |
| Sell | UNICYCIVE THERAPEUTICS INC | $349,605 | -16.6% | 647,416 | -8.9% | 0.02% | -14.8% | |
| XGN | Sell | EXAGEN INC | $351,742 | -13.8% | 146,559 | -2.6% | 0.02% | -11.5% |
| CUE | CUE BIOPHARMA INC | $265,896 | +27.8% | 93,297 | 0.0% | 0.02% | +30.8% | |
| IDN | INTELLICHECK INC | $249,188 | -20.6% | 124,594 | 0.0% | 0.02% | -20.0% | |
| CBIO | Sell | CATALYST BIOSCIENCES INC | $231,074 | -82.1% | 438,055 | -82.9% | 0.02% | -81.9% |
| IMAC | Sell | IMAC HLDGS INC | $234,263 | -49.7% | 1,174,253 | -4.5% | 0.02% | -50.0% |
| CYTK | New | CYTOKINETICS INC | $220,028 | – | 4,802 | +100.0% | 0.01% | – |
| SGU | New | STAR GROUP L Punit ltd partnr | $152,806 | – | 12,681 | +100.0% | 0.01% | – |
| RFL | RAFAEL HLDGS INC | $135,908 | +3.7% | 72,678 | 0.0% | 0.01% | +12.5% | |
| New | KINTARA THERAPEUTICS INC | $81,998 | – | 11,901 | +100.0% | 0.01% | – | |
| Sell | CYREN LTD | $71,983 | -48.2% | 116,214 | -17.9% | 0.01% | -44.4% | |
| SFT | SHIFT TECHNOLOGIES INCcl a | $45,620 | -67.4% | 200,000 | 0.0% | 0.00% | -66.7% | |
| TC BIOPHARM HOLDINGS PLC*w exp 02/08/202 | $21,047 | -27.4% | 235,294 | 0.0% | 0.00% | -50.0% | ||
| GUARDFORCE AI CO LTD*w exp 10/01/202 | $3,084 | -86.0% | 154,205 | 0.0% | 0.00% | -100.0% | ||
| HERAW | FTAC HERA ACQUISITION CORP*w exp 02/28/202 | $6,131 | -67.7% | 222,949 | 0.0% | 0.00% | -100.0% | |
| QUALTEK SERVICES INC*w exp 02/14/202 | $3,956 | -84.8% | 96,244 | 0.0% | 0.00% | -100.0% | ||
| FTCVW | Exit | FINTECH ACQUISITION CORP V*w exp 12/31/202 | $0 | – | -333,331 | -100.0% | -0.00% | – |
| IIIIW | Exit | INSU ACQUISITION CORP III*w exp 12/31/202 | $0 | – | -333,332 | -100.0% | -0.00% | – |
| Exit | FINTECH ACQUISITION CORP VI*w exp 03/31/202 | $0 | – | -240,600 | -100.0% | -0.00% | – | |
| KTRA | Exit | KINTARA THERAPEUTICS INC | $0 | – | -594,813 | -100.0% | -0.00% | – |
| Exit | SITIO ROYALTIES CORP*w exp 08/23/202 | $0 | – | -582,350 | -100.0% | -0.01% | – | |
| Exit | WEJO GROUP LIMITED | $0 | – | -118,175 | -100.0% | -0.01% | – | |
| AUTL | Exit | AUTOLUS THERAPEUTICS PLCcall | $0 | – | -70,300 | -100.0% | -0.01% | – |
| ZVO | Exit | ZOVIO INC | $0 | – | -1,961,635 | -100.0% | -0.02% | – |
| CDXS | Exit | CODEXIS INCcall | $0 | – | -50,000 | -100.0% | -0.02% | – |
| GMTX | Exit | GEMINI THERAPEUTICS INC | $0 | – | -257,672 | -100.0% | -0.03% | – |
| SNDX | Exit | SYNDAX PHARMACEUTICALS INCcall | $0 | – | -30,000 | -100.0% | -0.05% | – |
| Exit | HELIOGEN INC | $0 | – | -433,909 | -100.0% | -0.05% | – | |
| ALEC | Exit | ALECTOR INC | $0 | – | -85,514 | -100.0% | -0.05% | – |
| STIM | Exit | NEURONETICS INC | $0 | – | -380,325 | -100.0% | -0.08% | – |
| TCDA | Exit | TRICIDA INC | $0 | – | -229,610 | -100.0% | -0.16% | – |
| SMLR | Exit | SEMLER SCIENTIFIC INC | $0 | – | -72,397 | -100.0% | -0.18% | – |
| ARYD | Exit | ARYA SCIENCES ACQU CORP IVcl a | $0 | – | -285,730 | -100.0% | -0.18% | – |
| ONTF | Exit | ON24 INC | $0 | – | -538,906 | -100.0% | -0.31% | – |
| SBTX | Exit | SILVERBACK THERAPEUTICS INC | $0 | – | -1,249,863 | -100.0% | -0.43% | – |
| Exit | AKUMIN INC | $0 | – | -4,255,572 | -100.0% | -0.47% | – | |
| Exit | ARYA SCIENCES ACQUISITN CORP | $0 | – | -759,572 | -100.0% | -0.48% | – | |
| DRI | Exit | DARDEN RESTAURANTS INCput | $0 | – | -200,000 | -100.0% | -1.64% | – |
| SGMS | Exit | LIGHT & WONDER INC | $0 | – | -695,155 | -100.0% | -1.93% | – |
| TNL | Exit | TRAVEL PLUS LEISURE COcall | $0 | – | -919,100 | -100.0% | -2.03% | – |
| COST | Exit | COSTCO WHSL CORP NEW | $0 | – | -86,640 | -100.0% | -2.65% | – |
| COST | Exit | COSTCO WHSL CORP NEWput | $0 | – | -91,200 | -100.0% | -2.79% | – |
| IWM | Exit | ISHARES TRcall | $0 | – | -800,000 | -100.0% | -8.54% | – |
Original filings
The following EDGAR filing(s) were analyzed to create this report:
- View 13F-HR filed 2023-02-14
About Nantahala Capital Management
Nantahala Capital Management is a hedge fund that was founded in 2004 by Wil Harkey. The firm is headquartered in Connecticut and has additional offices in New York and North Carolina. Nantahala Capital Management primarily invests in the technology, healthcare, and consumer sectors. The firm has a long-term investment approach and seeks to identify undervalued companies with strong growth potential.
Wil Harkey serves as the CEO and Chief Investment Officer of Nantahala Capital Management. He has over 20 years of experience in the finance industry and previously worked at Goldman Sachs and Maverick Capital. In addition to Harkey, the firm's leadership team includes COO and General Counsel, David Kozak, and CFO, Michael Kozak.
Nantahala Capital Management has a strong track record of generating positive returns for its investors. The firm's flagship fund, the Nantahala Fund, has delivered an annualized return of over 20% since its inception in 2006. The firm's success can be attributed to its disciplined investment approach and focus on long-term value creation.
Overall, Nantahala Capital Management is a well-respected hedge fund with a talented leadership team and a strong track record of performance. However, as with any investment, it is important for investors to conduct their own due diligence and carefully consider the risks before investing in the firm's funds.
It's important to note that this information is for educational purposes only and has not been fact-checked. As with any investment, it's important to do your own research and consult with a financial advisor before making any investment decisions.
Top long-term holdings
| Name | Quarters owned | Latest quarter owned | Max weighting |
|---|---|---|---|
| ISHARES TR | 42 | Q3 2023 | 27.2% |
| CODEXIS INC | 42 | Q3 2023 | 3.9% |
| PATHWARD FINANCIAL INC | 35 | Q3 2023 | 6.3% |
| SCIENTIFIC GAMES CORP | 34 | Q3 2022 | 5.3% |
| DOVER MOTORSPORTS INC | 34 | Q3 2021 | 0.5% |
| GOLDEN ENTMT INC | 33 | Q3 2023 | 2.1% |
| QAD INC | 32 | Q3 2021 | 2.6% |
| SCIENTIFIC GAMES CORP | 31 | Q4 2021 | 7.7% |
| DOLBY LABORATORIES INC | 31 | Q4 2020 | 5.6% |
| LINCOLN EDL SVCS CORP | 31 | Q4 2021 | 0.7% |
View Nantahala Capital Management's complete holdings history.
Latest significant ownerships (13-D/G)
| Filed | Shares | Percentage | |
|---|---|---|---|
| AYTU BIOPHARMA, INC | June 16, 2023 | 1,086,812 | 19.7% |
| Acer Therapeutics Inc. | February 14, 2023 | 1,226,191 | 7.5% |
| Aeglea BioTherapeutics, Inc. | February 14, 2023 | 4,611,302 | 7.5% |
| AKUMIN INC. | February 14, 2023 | 2,206,960 | 2.5% |
| ALTA EQUIPMENT GROUP INC. | February 14, 2023 | 1,188,985 | 3.7% |
| Apollo Endosurgery, Inc. | February 14, 2023 | 4,056,627 | 9.9% |
| Autolus Therapeutics plc | February 14, 2023 | 7,782,018 | 4.7% |
| Bioventus Inc. | February 14, 2023 | 3,168,574 | 5.1% |
| CATALYST BIOSCIENCES, INC. | February 14, 2023 | 438,055 | 1.4% |
| Drive Shack Inc. | February 14, 2023 | 6,500,000 | 7.0% |
View Nantahala Capital Management's complete significant-ownership history.
Latest filings
| Type | Filed |
|---|---|
| 4 | 2024-03-21 |
| 4 | 2024-03-15 |
| SC 13G | 2024-03-11 |
| 13F-HR/A | 2024-02-15 |
| 13F-HR | 2024-02-14 |
| SC 13G/A | 2024-02-14 |
| SC 13G/A | 2024-02-14 |
| SC 13G/A | 2024-02-14 |
| SC 13G/A | 2024-02-14 |
| SC 13G/A | 2024-02-14 |
View Nantahala Capital Management's complete filings history.
All filings
- Holdings (13F-HR)
- Significant ownership (13-D/G)
- Insider transactions (4, 5, 6)
- Events (8-K)
- Shareholder votes (proxy)
View complete filings history.